Sysmex (OTCMKTS:SSMXY) Shares Gap Down - Time to Sell?

Key Points

• Sysmex shares gapped down from $12.90 to $12.45 on Thursday, and last traded at $12.91 with a volume of 2,942 shares.
• Analysts at Zacks Research upgraded Sysmex from a "strong sell" to a "hold" rating, but the stock has a consensus rating of "Hold" overall.
• In its recent quarterly earnings report, Sysmex posted an EPS of $0.05, missing estimates by $0.07, and reported revenues of $717.09 million, below the forecast of $807.27 million.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $12.90, but opened at $12.45. Sysmex shares last traded at $12.91, with a volume of 2,942 shares trading hands.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Sysmex from a "strong sell" rating to a "hold" rating in a research report on Thursday, August 14th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of "Hold".

Sysmex Trading Up 0.6%

The stock's 50 day simple moving average is $14.38 and its 200 day simple moving average is $16.62. The firm has a market cap of $7.94 billion, a PE ratio of 25.24 and a beta of 1.10. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.49 and a current ratio of 3.37.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.12 by ($0.07). Sysmex had a net margin of 9.35% and a return on equity of 10.20%. The firm had revenue of $717.09 million for the quarter, compared to analysts' expectations of $807.27 million. On average, sell-side analysts forecast that Sysmex Corporation ADR will post 0.57 earnings per share for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.